GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Taihe Group Inc (OTCPK:TIHE) » Definitions » Return-on-Tangible-Asset

TIHE (Taihe Group) Return-on-Tangible-Asset : 0.00% (As of Mar. 2023)


View and export this data going back to . Start your Free Trial

What is Taihe Group Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Taihe Group's annualized Net Income for the quarter that ended in Mar. 2023 was $-0.08 Mil. Taihe Group's average total tangible assets for the quarter that ended in Mar. 2023 was $0.00 Mil. Therefore, Taihe Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2023 was 0.00%.

The historical rank and industry rank for Taihe Group's Return-on-Tangible-Asset or its related term are showing as below:

TIHE's Return-on-Tangible-Asset is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -4.07
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Taihe Group Return-on-Tangible-Asset Historical Data

The historical data trend for Taihe Group's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taihe Group Return-on-Tangible-Asset Chart

Taihe Group Annual Data
Trend Dec20 Dec21 Dec22
Return-on-Tangible-Asset
- - -

Taihe Group Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Taihe Group's Return-on-Tangible-Asset

For the Diagnostics & Research subindustry, Taihe Group's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taihe Group's Return-on-Tangible-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Taihe Group's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Taihe Group's Return-on-Tangible-Asset falls into.


;
;

Taihe Group Return-on-Tangible-Asset Calculation

Taihe Group's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2022 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=-0.044/( (0+0)/ 1 )
=-0.044/0
=N/A %

Taihe Group's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2023 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2023 )  (Q: Dec. 2022 )(Q: Mar. 2023 )
=-0.076/( (0+0)/ 1 )
=-0.076/0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2023) net income data.


Taihe Group  (OTCPK:TIHE) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Taihe Group Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Taihe Group's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Taihe Group Business Description

Traded in Other Exchanges
N/A
Address
Indonesian Street City, Batu Licin, Bintan Island, Kepulauan Riau, IDN, 29151
Taihe Group Inc formerly, NuOncology Labs Inc is a United States based company and provides predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. NLAB's operations include development, identification, testing and licensing of cancer treatment compounds.

Taihe Group Headlines

No Headlines